Processes for preparing oxazolidinone compounds

Abstract

The invention relates to crystalline forms and processes for preparing a compound of Formula I (I) and pharmaceutically acceptable salts thereof which are useful for the treatment of bacterial infections, particularly mycobacterial infections. The invention also relates to intermediates used in the processes for preparing the compound of Formula I for the treatment of mycobacterial infections such as those caused by Mycobacteria tuberculosis.

Dependencies are inferred from the claim text.